Clinical Value of Circulating Microribonucleic Acids miR-1 and miR-21 in Evaluating the Diagnosis of Acute Heart Failure in Asymptomatic Type 2 Diabetic Patients

miR-1, miR-21, and galectin-3 in hypertensive patients with symptomatic heart failure and left ventricular hypertrophy

(2018) Mariusz Tomaniak et al.   Kardiologia Polska

MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin

(2018) Beibei Dai et al.   Cardiovascular Diabetology

Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation

(2018) Jacob O'Brien et al.   Frontiers in Endocrinology

Galectin-3 and risk of cardiovascular events and all-cause mortality in type 2 diabetes

(2018) Kathryn C.B. Tan et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

The First Harmonic of Radial Pulse as an Early Predictor of Silent Coronary Artery Disease and Adverse Cardiac Events in Type 2 Diabetic Patients

(2018) Chi-Wei Chang et al.   Cardiology Research and Practice

Effect of Natriuretic Peptide–Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction

(2017) G. Michael Felker et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Altered levels of circulating cytokines and microRNAs in lean and obese individuals with prediabetes and type 2 diabetes

(2017) Yury O. Nunez Lopez et al.   Molecular BioSystems

Prognostic Value of Serial Galectin‐3 Measurements in Patients With Acute Heart Failure

(2017) Laura C. van Vark et al.   Journal of the American Heart Association

Decreased serum microRNA-21 level is associated with obesity in healthy and type 2 diabetic subjects

(2017) Samira Ghorbani et al.   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY

N-terminal pro-brain natriuretic peptide and cardiovascular or all-cause mortality in the general population: A meta-analysis

(2017) Zhaohua Geng et al.   Scientific Reports

Impact of diabetes on the predictive value of heart failure biomarkers

(2016) Nuria Alonso et al.   Cardiovascular Diabetology

Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance

(2016) Pingping Li et al.   CELL

MicroRNA-21 Lowers Blood Pressure in Spontaneous Hypertensive Rats by Upregulating Mitochondrial TranslationClinical Perspective

(2016) Huaping Li et al.   CIRCULATION

Viral Vector-Based Targeting of miR-21 in Cardiac Nonmyocyte Cells Reduces Pathologic Remodeling of the Heart

(2016) Deepak Ramanujam et al.   MOLECULAR THERAPY

Circulating microribonucleic acids miR-1, miR-21 and miR-208a in patients with symptomatic heart failure: Preliminary results

(2015) Grażyna Sygitowicz et al.   Archives of Cardiovascular Diseases

Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender

(2015) Piercarlo Ballo et al.   Clinical Research in Cardiology

Acute heart failure in the emergency department: a follow-up study

(2015) Andrea Fabbri et al.   Internal and Emergency Medicine

Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial

(2015) Faiez Zannad et al.   LANCET

Impact of Diabetes on Epidemiology, Treatment, and Outcomes of Patients With Heart Failure

(2015) Alessandra Dei Cas et al.   JACC-Heart Failure

Micro-RNA 21Targets Dual Specific Phosphatase 8 to Promote Collagen Synthesis in High Glucose–Treated Primary Cardiac Fibroblasts

(2014) Shulei Liu et al.   CANADIAN JOURNAL OF CARDIOLOGY

A systematic review of BNP and NT-proBNP in the management of heart failure: overview and methods

(2014) Mark Oremus et al.   HEART FAILURE REVIEWS

miRNA-1: functional roles and dysregulation in heart disease

(2014) Lian Duan et al.   Molecular BioSystems

Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction

(2013) Olof Gidlöf et al.   BMC Cardiovascular Disorders

Galectin-3 Deficiency Accelerates High-Fat Diet-Induced Obesity and Amplifies Inflammation in Adipose Tissue and Pancreatic Islets

(2013) N. N. Pejnovic et al.   DIABETES

Increased Adiposity, Dysregulated Glucose Metabolism and Systemic Inflammation in Galectin-3 KO Mice

(2013) Jingbo Pang et al.   PLoS One

Therapeutic Cardiac‐Targeted Delivery of miR‐1 Reverses Pressure Overload–Induced Cardiac Hypertrophy and Attenuates Pathological Remodeling

(2013) Ioannis Karakikes et al.   Journal of the American Heart Association

MiRNA-21 Reverses High Glucose and High Insulin Induced Insulin Resistance in 3T3-L1 Adipocytes through Targeting Phosphatase and Tensin Homologue

(2012) H.-y. Ling et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

N-terminal pro-brain natriuretic peptide could be a marker of subclinical atherosclerosis in patients with type 2 diabetes

(2012) Takafumi Senmaru et al.   HEART AND VESSELS

Elevated plasma microRNA-1 predicts heart failure after acute myocardial infarction

(2012) Rong Zhang et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Myocardial and circulating levels of microRNA-21 reflect left ventricular fibrosis in aortic stenosis patients

(2012) Ana V. Villar et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Regulation and function of miRNA-21 in health and disease

(2011) Regalla Kumarswamy et al.   RNA Biology

Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes

(2010) Anna Zampetaki et al.   CIRCULATION RESEARCH

Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction

(2009) Jing Ai et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

B-Type Natriuretic Peptides and Cardiovascular Risk

(2009) Emanuele Di Angelantonio et al.   CIRCULATION

Galectin-3: a novel mediator of heart failure development and progression

(2009) Rudolf A. de Boer et al.   EUROPEAN JOURNAL OF HEART FAILURE

MicroRNA-21 protects against the H2O2-induced injury on cardiac myocytes via its target gene PDCD4

(2009) Yunhui Cheng et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

(2008) Thomas Thum et al.   NATURE